• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Intensive Care . Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infection

tetano

Editor, Senior Moderator
Ann Intensive Care


. 2025 Mar 24;15(1):38.
doi: 10.1186/s13613-025-01443-1. Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infection

Paul Quentric[SUP] 1 2 [/SUP], Jean-Luc Charuel[SUP] 3 [/SUP], Quentin Moyon[SUP] 2 4 [/SUP], Guillaume Hékimian[SUP] 4 [/SUP], Karim Dorgham[SUP] 1 [/SUP], François Lifermann[SUP] 5 [/SUP], Mathieu Kerneis[SUP] 6 7 [/SUP], Alexis Mathian[SUP] 1 2 [/SUP], Karim Aacha[SUP] 6 [/SUP], Isabelle Melki[SUP] 8 [/SUP], Juliette Chommeloux[SUP] 4 [/SUP], Matthieu Petit[SUP] 4 [/SUP], Melchior Gautier[SUP] 4 [/SUP], Pierre Bay[SUP] 9 [/SUP], Philippe Rouvier[SUP] 10 [/SUP], Etienne Charpentier[SUP] 11 [/SUP], Omaira da Mata-Jardin[SUP] 1 [/SUP], Lucie Lefevre[SUP] 4 [/SUP], Christophe Parizot[SUP] 3 [/SUP], Ouriel Saura[SUP] 4 [/SUP], David Levy[SUP] 4 [/SUP], Sofia Ortuno[SUP] 4 [/SUP], Matthieu Schmidt[SUP] 4 7 [/SUP], Charles-Edouard Luyt[SUP] 4 7 [/SUP], Guy Gorochov[SUP] 1 3 [/SUP], Zahir Amoura[SUP] 1 4 [/SUP], Alain Combes[SUP] 4 7 [/SUP], Marc Pineton de Chambrun[SUP] 12 13 14 15 [/SUP]



Affiliations
Abstract

Background: Fulminant myocarditis (FM) is a severe condition primarily triggered by viruses. Anti-RNA polymerase III autoantibodies (RNApol3) which are typically found in patients with severe systemic sclerosis, have been reported in patients with influenza-related FM. Our objective is to provide additional insight into RNApol3-associated FM.
Methods: We retrospectively included all patients admitted to our institution between January 2013 and June 2023 with acute myocarditis and positive serum RNApol3. We compared their characteristics, etiologies, and outcomes with those of a cohort of RNApol3 negative acute myocarditis.
Results: Twenty-nine RNApol3-positive patients, comprising 83% females with a mean age of 39 ± 12 years, were included in this study. Each patient was admitted to the intensive care unit at least once and 11 (38%) relapsed. Triggers included influenza virus in 55% and SARS-CoV-2 virus in 48% of cases. The lowest left ventricular ejection fraction was 10 [5-10] % and the highest troponin value was 82 [22-360] times the ULN. Patients required dobutamine (94%), veno-arterial extracorporeal membrane oxygenation (85%) and pericardiocentesis (38%). At the last follow-up, 76% of patients were still alive, while 7% had undergone cardiac transplantation, and 3% required a left ventricular assist device. Compared to RNApol3-negative cases, RNApol3-positive myocarditis was associated with female gender, fulminant evolution, tamponade, a higher likelihood of being caused by a proven viral infection, and a higher rate of relapse.
Conclusion: RNApol3-associated myocarditis is an emerging disease linking autoimmunity and infection and a unique cause of acquired, pathogen-specific, organ-specific immunodeficiency. RNApol3 should be screened in all cases of FM, especially in young women infected by RNA viruses. The risk of FM in RNApol3-positive systemic sclerosis needs further investigation.

Keywords: Anti-RNA-polymerase III autoantibodies; Autoimmunity; Extracorporeal membrane oxygenation; Fulminant myocarditis; Systemic sclerosis; Viral infection.

 
Back
Top Bottom